151751-Najiba-Chargi

194 CHAPTER 10 15. Chargi N, Ansari E, Huiskamp LFJ, Bol G, de Bree R. Agreement between skeletal muscle mass measurements using computed to- mography imaging andmagnetic resonance imaging in head and neck cancer patients. Oral Oncol . 2019;99:104341. doi:10.1016/j. oraloncology.2019.06.022 16. Mourtzakis M, Prado CMM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE. A prac - tical and precise approach to quantification of body composition in cancer patients using computed tomography images ac- quired during routine care. Appl Physiol Nutr Metab . 2008;33(5):997-1006. doi:10.1139/ H08-075 17. Swartz JE, Pothen AJ, Wegner I, et al. Feasibility of using head and neck CT im - aging to assess skeletal muscle mass in head and neck cancer patients. Oral Oncol . 2016;62:28-33. doi:10.1016/j.oraloncolo - gy.2016.09.006 18. Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol . 1998;147(8):755-763. doi:10.1093/oxford - journals.aje.a009520 19. Sealy MJ, Dechaphunkul T, Van Der Schans CP, et al. Low muscle mass is associated with early termination of chemotherapy related to toxicity in patients with head and neck cancer. 2019. doi:10.1016/j. clnu.2019.02.029 20. Dijksterhuis WPM, Pruijt MJ, van der Woude SO, et al. Association between body com - position, survival, and toxicity in advanced esophagogastric cancer patients receiv- ing palliative chemotherapy. J Cachexia Sarcopenia Muscle . 2019;10(1):199-206. doi:10.1002/jcsm.12371 21. Basile D, Corvaja C, Caccialanza R, Aprile G. Sarcopenia: Looking to muscle mass to better manage pancreatic cancer patients. Curr Opin Support Palliat Care . 2019;13(4):279-285. doi:10.1097/ SPC.0000000000000455 22. Hilmi M, Jouinot A, Burns R, et al. Body com - position and sarcopenia: The next-genera- tion of personalized oncology and pharma- cology? Pharmacol Ther . 2019;196:135-159. doi:10.1016/j.pharmthera.2018.12.003 23. Pamoukdjian F, Bouillet T, Lévy V, Soussan M, Zelek L, Paillaud E. Prevalence and pre - dictive value of pre-therapeutic sarcopenia in cancer patients: A systematic review. Clin Nutr . 2018;37(4):1101-1113. doi:10.1016/j. clnu.2017.07.010 24. Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sar- copenic obesity in patients with solid tu- mours of the respiratory and gastrointesti- nal tracts: a population-based study. Lancet Oncol . 2008;9(7):629-635. doi:10.1016/ S1470-2045(08)70153-0 25. Morley JE, Baumgartner RN, Roubenoff R, Mayer J, Nair KS. Sarcopenia. J Lab Clin Med . 2001;137(4):231-243. doi:10.1067/ mlc.2001.113504